A randomized, open label, cross-over study comparing effectiveness for the montelukast sodium with comparator in mild to moderate persistent asthmatics
Latest Information Update: 05 May 2022
At a glance
- Drugs Montelukast (Primary) ; Theophylline
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 01 Feb 2007 Status changed from in progress.
- 31 Dec 2005 New trial record.